Hepatitis B virus (HBV) is a non-cytopathic, hepatotropic virus with the potential to cause a
persistent infection, ultimately leading to cirrhosis and hepatocellular carcinoma. Over the …

Background Emerging data suggest that statins, aspirin and metformin may protect against
hepatocellular carcinoma (HCC) development. However, prior meta‐analyses were limited …

Background & Aims Diabetes mellitus (DM) is known to increase the risk of hepatocellular
carcinoma (HCC) among individuals with chronic hepatitis C (CHC). We aimed to evaluate …

Summary Background Chemoprevention with NSAIDs, including aspirin, and anti‐platelet
therapy (APT), has been suggested to reduce the incidence and recurrence of …

Preclinical and clinical studies provide evidence for aspirin as a preventative agent for
cancer. Compelling direct evidence supports a chemopreventive effect of aspirin in …

Simple Summary Epidemiological and experimental studies have demonstrated that aspirin
(acetylsalicylic acid) may prevent the incidence of some types of human cancer, including …

The global burden of chronic liver disease (CLD) is substantial. Due to the limited indication
of and accessibility to antiviral therapy in viral hepatitis and lack of effective pharmacological …

Background Hepatocellular carcinoma (HCC) is one of the leading causes of cancer-related
death, so we should be concerned and look for effective/less-harmful treatments than …

Purpose To compare the survival outcomes of postoperative adjuvant aspirin with surgery
alone in patients with hepatitis B virus (HBV)-related hepatocellular carcinoma (HCC) and …

Preclinical studies highlighted potential therapeutic applications of aspirin and statins as
anticancer agents based on their pleiotropic effects. Epidemiologic studies suggested the …